Mono vaccines reduce the number of shots your child needs while protecting against only one serious diseases The global market for Mono Vaccine was estimated to be worth US$ 14250 million in 2023…
Author: QYResearch
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 6 countries (include United States, Germany, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Specialty Pharmaceutical Market Growth 2024-2030: Targeting Key Segments and Strategies for Expansion
Specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch. The global market for Specialty Pharmaceutical was estimated to be worth US$ million in 2023 and is…
Combination Vaccine Market Growth 2024-2030: Targeting Key Segments and Strategies for Expansion
Combination vaccines reduce the number of shots your child needs while protecting against several serious diseases The global market for Combination Vaccine was estimated to be worth US$ 4615 million in 2023 and…
Nilotinib Market Growth 2024-2030: Targeting Key Segments and Strategies for Expansion
Nilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). The global market for Nilotinib was estimated to be worth US$ 1923 million in 2023 and is forecast to…
Hydroxyethyl Starch Market Comprehensive Report 2024: Size, Growth Prospects, and Regional Analysis
Hydroxyethyl starch (HES/HAES), is a nonionic starch derivative, used as a volume expander in intravenous therapy. The global market for Hydroxyethyl Starch was estimated to be worth US$ million in 2023 and is forecast to…
Tasigna Global Market Research 2024: Industry Trends, Share, Market Size, and Outlook
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia. The global market for Tasigna was estimated to be worth US$ 1923 million in 2023 and is forecast to a readjusted size…
Afinitor Market Strategies for Expansion Analysis Report: Opportunities and Challenges Ahead
Afinitor (everolimus) is a brand-name prescription medication. It’s used to treat certain types of cancers, tumors, and seizures. The global market for Afinitor was estimated to be worth US$ 512 million in 2023…
Rituximab Market Opportunity Analysis Report 2024: Regional Markets and Segments
Rituximab is a type of antibody therapy that can be used alone or with chemotherapy. The global market for Rituximab was estimated to be worth US$ 10350 million in 2023 and is forecast…
Revlimid Market Comprehensive Report 2024: Size, Growth Prospects, and Regional Analysis
REVLIMID® (lenalidomide), an immunomodulatory therapy used to treat people with multiple myeloma The global market for Revlimid was estimated to be worth US$ 10350 million in 2023 and is forecast to a…
IVIg Powder Global Market Research 2024: Industry Trends, Share, Market Size, and Outlook
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors. The global market for IVIg Powder was estimated to be worth US$…